Targeted delivery of polypeptide nanoparticle for treatment of traumatic brain injury

Peng Wu,1 Haitian Zhao,2 Xingchun Gou,3 Xingwang Wu,4 Shenqi Zhang,1 Gang Deng,1 Qianxue Chen11Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, People’s Republic of China; 2School of Chemistry and Chemical Engineering, Harbin Institute of Technology, Ha...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Wu P, Zhao H, Gou X, Wu X, Zhang S, Deng G, Chen Q
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2019
Materias:	Traumatic Brain Injury Nanoparticle Tat-NR2B9c CAQK Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/85f99db9dc22472f81b9d8e2a7b35b60
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:85f99db9dc22472f81b9d8e2a7b35b60
record_format	dspace
spelling	oai:doaj.org-article:85f99db9dc22472f81b9d8e2a7b35b602021-12-02T04:56:03ZTargeted delivery of polypeptide nanoparticle for treatment of traumatic brain injury1178-2013https://doaj.org/article/85f99db9dc22472f81b9d8e2a7b35b602019-05-01T00:00:00Zhttps://www.dovepress.com/targeted-delivery-of-polypeptide-nanoparticle-for-treatment-of-traumat-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Peng Wu,1 Haitian Zhao,2 Xingchun Gou,3 Xingwang Wu,4 Shenqi Zhang,1 Gang Deng,1 Qianxue Chen11Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, People’s Republic of China; 2School of Chemistry and Chemical Engineering, Harbin Institute of Technology, Harbin, 150001, People’s Republic of China; 3Shaanxi Key Laboratory of Brain Disorders & Institute of Basic and Translational Medicine, Xi’an Medical University, Xi’an 710021, People’s Republic of China; 4Department of Radiology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230020, People’s Republic of ChinaBackground and purpose: Traumatic brain injury (TBI) is a major disease without effective treatment. Recently, Tat-NR2B9c peptide emerged as a promising neuroprotective agent, but limited in clinical translation by it low brain penetrability. We synthesized Tat-NR2B9c loaded self-assembled activatable protein nanoparticles, termed TN-APNPs, and demonstrated that TN-APNPs enhanced the delivery of Tat-NR2B9c to the brain lesion in stroke. Herein we developed a novel approach to further engineering TN-APNPs for targeted delivery of Tat-NR2B9c to the injured brain with enhanced efficiency through conjugation of CAQK or CCAQK, a short peptide.Methods: Short peptide-conjugated TN-APNPs were synthesized by conjugated with CAQK or CCAQK via a click condensation reaction with CBT, then analyzed by dynamic light scattering, transmission electron microscopy and thrombin responsive assay. Characterization of short peptide-conjugated TN-APNPs were investigated by using cell excitotoxicity assay and transwell blood-brain-barrier model in vitro, and pharmacokinetics, IVIS imaging system and confocal analysis in TBI-bearing mice. Evaluation of therapeutic effects were analyzed by H&E staining, Elevated Plus Maze analysis and Rotarod test.Results: CAQK-conjugated TN-APNPs (C-TN-APNPs) and CCAQK-conjugated TN-APNPs (CC-TN-APNPs) were spherical in morphology and 30 nm in diameter. In vitro studies revealed that TN-APNPs, C-TN-APNPs and CC-TN-APNPs were responsive to thrombin cleavage, reduced the cytotoxicity of Tat-NR2B9c, and increased BBB permeability of Tat-NR2B9c. CC-TN-APNPs demonstrated the better circulation time, better targeting ability and penetrating efficiency to the injured brain, and better therapeutic benefits in vivo studies.Conclusion: This study demonstrated CC-TN-APNPs as a promising therapeutic for clinical management of TBI.Keywords: traumatic brain injury, Nanoparticle, Tat-NR2B9c, CAQK, CCAQKWu PZhao HGou XWu XZhang SDeng GChen QDove Medical PressarticleTraumatic Brain InjuryNanoparticleTat-NR2B9cCAQKMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 14, Pp 4059-4069 (2019)
institution	DOAJ
collection	DOAJ
language	EN
topic	Traumatic Brain Injury Nanoparticle Tat-NR2B9c CAQK Medicine (General) R5-920
spellingShingle	Traumatic Brain Injury Nanoparticle Tat-NR2B9c CAQK Medicine (General) R5-920 Wu P Zhao H Gou X Wu X Zhang S Deng G Chen Q Targeted delivery of polypeptide nanoparticle for treatment of traumatic brain injury
description	Peng Wu,1 Haitian Zhao,2 Xingchun Gou,3 Xingwang Wu,4 Shenqi Zhang,1 Gang Deng,1 Qianxue Chen11Department of Neurosurgery, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, People’s Republic of China; 2School of Chemistry and Chemical Engineering, Harbin Institute of Technology, Harbin, 150001, People’s Republic of China; 3Shaanxi Key Laboratory of Brain Disorders & Institute of Basic and Translational Medicine, Xi’an Medical University, Xi’an 710021, People’s Republic of China; 4Department of Radiology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, 230020, People’s Republic of ChinaBackground and purpose: Traumatic brain injury (TBI) is a major disease without effective treatment. Recently, Tat-NR2B9c peptide emerged as a promising neuroprotective agent, but limited in clinical translation by it low brain penetrability. We synthesized Tat-NR2B9c loaded self-assembled activatable protein nanoparticles, termed TN-APNPs, and demonstrated that TN-APNPs enhanced the delivery of Tat-NR2B9c to the brain lesion in stroke. Herein we developed a novel approach to further engineering TN-APNPs for targeted delivery of Tat-NR2B9c to the injured brain with enhanced efficiency through conjugation of CAQK or CCAQK, a short peptide.Methods: Short peptide-conjugated TN-APNPs were synthesized by conjugated with CAQK or CCAQK via a click condensation reaction with CBT, then analyzed by dynamic light scattering, transmission electron microscopy and thrombin responsive assay. Characterization of short peptide-conjugated TN-APNPs were investigated by using cell excitotoxicity assay and transwell blood-brain-barrier model in vitro, and pharmacokinetics, IVIS imaging system and confocal analysis in TBI-bearing mice. Evaluation of therapeutic effects were analyzed by H&E staining, Elevated Plus Maze analysis and Rotarod test.Results: CAQK-conjugated TN-APNPs (C-TN-APNPs) and CCAQK-conjugated TN-APNPs (CC-TN-APNPs) were spherical in morphology and 30 nm in diameter. In vitro studies revealed that TN-APNPs, C-TN-APNPs and CC-TN-APNPs were responsive to thrombin cleavage, reduced the cytotoxicity of Tat-NR2B9c, and increased BBB permeability of Tat-NR2B9c. CC-TN-APNPs demonstrated the better circulation time, better targeting ability and penetrating efficiency to the injured brain, and better therapeutic benefits in vivo studies.Conclusion: This study demonstrated CC-TN-APNPs as a promising therapeutic for clinical management of TBI.Keywords: traumatic brain injury, Nanoparticle, Tat-NR2B9c, CAQK, CCAQK
format	article
author	Wu P Zhao H Gou X Wu X Zhang S Deng G Chen Q
author_facet	Wu P Zhao H Gou X Wu X Zhang S Deng G Chen Q
author_sort	Wu P
title	Targeted delivery of polypeptide nanoparticle for treatment of traumatic brain injury
title_short	Targeted delivery of polypeptide nanoparticle for treatment of traumatic brain injury
title_full	Targeted delivery of polypeptide nanoparticle for treatment of traumatic brain injury
title_fullStr	Targeted delivery of polypeptide nanoparticle for treatment of traumatic brain injury
title_full_unstemmed	Targeted delivery of polypeptide nanoparticle for treatment of traumatic brain injury
title_sort	targeted delivery of polypeptide nanoparticle for treatment of traumatic brain injury
publisher	Dove Medical Press
publishDate	2019
url	https://doaj.org/article/85f99db9dc22472f81b9d8e2a7b35b60
work_keys_str_mv	AT wup targeteddeliveryofpolypeptidenanoparticlefortreatmentoftraumaticbraininjury AT zhaoh targeteddeliveryofpolypeptidenanoparticlefortreatmentoftraumaticbraininjury AT goux targeteddeliveryofpolypeptidenanoparticlefortreatmentoftraumaticbraininjury AT wux targeteddeliveryofpolypeptidenanoparticlefortreatmentoftraumaticbraininjury AT zhangs targeteddeliveryofpolypeptidenanoparticlefortreatmentoftraumaticbraininjury AT dengg targeteddeliveryofpolypeptidenanoparticlefortreatmentoftraumaticbraininjury AT chenq targeteddeliveryofpolypeptidenanoparticlefortreatmentoftraumaticbraininjury
_version_	1718400962825027584

Targeted delivery of polypeptide nanoparticle for treatment of traumatic brain injury

Ejemplares similares